A purple and pink letter v on a white background.
November 24, 2021

Device Spotlight: What Venus Bliss™ Can Bring to Your Practice

It should come as no surprise that fat reduction treatments are the most popular non-invasive body treatment in aesthetics. As many as 86% of people are bothered by excess weight on their body, and they re looking for a solution   that can deliver the results they want without the pain,   high cost,   and downtime typically associated with surgery . The answer?   Venus Bliss . Adding non-invasive lipolysis to your clinic offerings with Venus Bliss   is a sure way to tap into the lucrative market of fat reduction treatments.     

Non-Invasive Lipolysis: Market Overview  

N on-invasive body contouring is   the fastest-growing area of cosmetic dermatology   today . According to   the American Society of Aesthetic Plastic Surgeons ,   the number of non- invasive   fat reduction procedures performed tripled   between   2012 to 2017 , and t his growth shows no sign of slowing. The global non- invasive   fat reduction market is expected to expand at   a rate of over   15% and be valued at $2.5 billion by 2025 .  

Why Venus  Bliss ™  Is the Best Choice for Patients  

Results.   In terms of results, Venus Bliss   delivers. One study   showed a 24 %   reduction in fat volume   when treating the   abdomen and flanks , two stubborn areas for fat retention that are a top priority for patients.   Most importantly, patients report treatment satisfaction of more than 90%, and only mild side effects such as slight soreness and minor swelling are seen 1 .  

Safety.   The treatment is completely non-invasive, which means the use of this laser lipolysis device avoids complications that often arise , or with   invasive procedures such as liposuction.   Like   all our patented technologies , it is safe for all skin types.  

Comfort.   With all aesthetic treatments, we ve seen that comfort is an important factor to patients when considering trying a new treatment. Venus Bliss   ensures a comfortable experience with its   contact cooling system , which regulates temperature and prevents   damage to the surface of the skin.  

No Downtime.   Fat reduction treatments with Venus Bliss   require   no downtime   whatsoever. Only lasting 15-30 minutes, the sessions are convenient, quick, and allow patients to return to their regular daily activities immediately.   

Venus  Bliss ™ : Device Technology That Works  

Venus Bliss   fat reduction treatments are powered by the latest in diode laser technology, which   works by heating the adipose tissue layer to induce lipolysis and start apoptotic processes.   (MP) 2 applicators emit a   1064 nm wavelength, which effectively passes through the skin and is absorbed by the adipose tissue layer where it heats the fat cells.   The targeted f at cells release stored triglycerides, causing some to shrink and others to destruct completely. Leftover cellular debris is processed   out   by the body through the lymphatic system.   Here is an in-depth look at the core technologies powering the device:    

DIODE LASER TECHNOLOGY FOR LIPOLYSIS  

  • 4 diode laser applicators that can be activated individually and placed in various configurations on a belt  
  • Treatment area of each diode laser applicator measures 36 cm 2 , versus the competitor s 24 cm 2   spot size  
  • With 1064 nm wavelength and skin-contact cooling mechanism, laser energy is capable of safely and effectively penetrating into hypodermis to affect adipose tissue without harming skin s   surface  

(MP) 2 APPLICATOR  

  • Powered by Multi-Polar Radio Frequency and Pulsed Electro Magnetic Fields (PEMF), with   VariPulse   technology  
  • Tightens skin* and reduces circumference*, giving the body a more contoured appearance  
  • Also reduces cellulite for smoother, firmer looking buttocks and thighs  
  • Dual multi-polar electrode crown design and unique array of electrodes allows for fast and efficient treatment of large areas  
  • Delivers significant depth of impact of up to 4.5 cm for greater effect on fat  

VARIPULSE ™   TECHNOLOGY  

  • Adjustable pulsed suction integrated in (MP) 2 applicator to facilitate deep effect on tissue  
  • Enhances penetration and effects of RF energy by improving contact surface between electrodes and tissue  
  • Increases blood flow and enhances lymphatic drainage  
  • Enables operator to reach and maintain therapeutically effective temperature fast, while maintaining patient comfort  

Why Venus  Bliss ™  Is t he  Best Choice f or  Your Clinic

Venus Concept   is known for our easy-to-use, non-invasive technologies that serve customers in a safe and effective manner. Our innovative products help you   reach a wider   patient base all while providing services that are in line with the needs of the modern aesthetic customer .   Backed by clinically validated effectiveness,   Venus Bliss   is a comprehensive solution   that   allows you to deliver results for your patients and with no per-treatment usage fees for you as the provider.   With the increasing demand for non-invasive fat reduction treatments, Venus Bliss   offers a high ROI and helps you to g row your practice by offering patients   the most   innovative technology that is clinically   proven   to meet their aesthetic needs.  

To bring this state-of-the-art aesthetic device to your practice, speak to one of our experts today.    

DISCLAIMER:

*The (MP)2 applicator is licensed by Health Canada and CE marked for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction.

REFERENCES:

1. Mikaela Kislevitz, MD, BSN, RN, Christine Wamsley, BA, Alison Kang, MD, Suzanne Kilmer, MD, John Hoopman, CMLSO, Jennifer Barillas, BS, Jeffrey M Kenkel, MD, Clinical Evaluation of the Safety and Efficacy of a 1060-nm Diode Laser for Non-Invasive Fat Reduction of the Abdomen, Aesthetic Surgery Journal , Volume 41, Issue 10, October 2021, Pages 1155–1165, https://doi.org/10.1093/asj/sjaa418

July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.